Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Decision Making returned 12 record(s)
|
|
Tuesday, 07/31/2018
|
Machine Learning to Evaluate the Quality of Patient Reported Epidemiological Data
Robert L. Wood, Resonate & Wichita State University; Futoshi Yumoto, Resonate; Rochelle Tractenberg, Georgetown University
|
Benefit Cost Ratio Analysis in Oncology Drug Development: Single Arm Vs RCT
Thomas Jemielita, Merck & Co.; Cong Chen, Merck & Co.
9:15 AM
|
A Model-Based Conditional Power Assessment for Decision Making in Randomized Controlled Trial Studies
Baiming Zou, University of Florida; Jianwen Cai, University of North Carolina; Gary G. Koch, University of North Carolina; Haibo Zhou, University of North Carolina; Fei Zou, University of North Carolina at Chapel Hill
9:20 AM
|
Leveraging Bayesian Methods, Modeling, and Simulation to Improve Decision-Making and Increase Probability of Success
Karen Price; Stephen Ruberg, Analytix Thinking, LLC
9:55 AM
|
|
Wednesday, 08/01/2018
|
Deriving and Validating New "Outcome" Variables in Patient Reported Epidemiological Data
Futoshi Yumoto, Resonate; Rochelle Tractenberg, Georgetown University
|
Interpretable Analysis of Team Performance in Soccer Using Tracking Data: a Hybrid of Supervised and Unsupervised Methods.
Paul David Power, STATS
8:35 AM
|
Worldwide Statistics Without Borders Projects: Statistics, Data Visualization, and Decision Making
Ella Temprosa, George Washington University
8:35 AM
|
Evaluating Different Analytic Strategies to Translate Real World Data to Robust Evidence for Decision Making
Hongwei Wang, AbbVie Inc; Weili He, AbbVie; Yabing Mai, AbbVie, Inc; Meijing Wu, AbbVie; Dajun Tian, Chiltern
2:05 PM
|
|
Thursday, 08/02/2018
|
Real World Data and Evidence in Health Care Decision Making
Kun Chen, AbbVie Inc; Weili He, AbbVie; Hongwei Wang, AbbVie Inc; Yabing Mai, AbbVie, Inc; Qiming Liao, AbbVie Inc
8:35 AM
|
Utility and Challenges of Applying Quantitative Benefit-Risk Assessment for Regulatory Decision Making
Weili He, AbbVie; Bo Fu, Astellas Pharma Inc.; John Scott, FDA
8:50 AM
|
|
|
